Half-year report · HY
3762.TEDINET S100X3O0
Period2025-04-01 → 2025-09-30
Filed2025-11-14
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 48
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥33.4bn | 2025-04-01 → 2025-09-30 | Cons. | Revenue IFRS |
| Revenue | ¥64.9bn | 2024-04-01 → 2025-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥30.8bn | 2024-04-01 → 2024-09-30 | Cons. | Revenue IFRS |
| Operating income | ¥3.2bn | 2025-04-01 → 2025-09-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥3.0bn | 2024-04-01 → 2024-09-30 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥3.2bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥6.4bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥2.8bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥2.1bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥4.1bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥1.7bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥2.2bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss IFRS |
| Net income | ¥4.5bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥1.8bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss IFRS |
| Total assets | ¥112.1bn | at 2025-09-30 | Cons. | Assets IFRS |
| Total assets | ¥105.5bn | at 2025-03-31 | Cons. | Assets IFRS |
| Total assets | ¥94.3bn | at 2024-09-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥80.6bn | at 2025-09-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥75.5bn | at 2025-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥31.5bn | at 2025-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥30.0bn | at 2025-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥28.1bn | at 2024-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥27.0bn | at 2024-03-31v | Cons. | Equity IFRS |
| Equity (owners) | ¥25.6bn | at 2025-09-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥24.2bn | at 2025-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥22.7bn | at 2024-09-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥31.0bn | at 2025-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥27.3bn | at 2025-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥27.5bn | at 2024-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥27.3bn | at 2024-03-31v | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥6.5bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥6.8bn | 2024-04-01 → 2025-03-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥2.5bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥757m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥6.0bn | 2024-04-01 → 2025-03-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥460m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥2.1bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥799m | 2024-04-01 → 2025-03-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥1.8bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥52.4 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥101.01 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥42.56 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥52.24 | 2025-04-01 → 2025-09-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥100.7 | 2024-04-01 → 2025-03-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥42.44 | 2024-04-01 → 2024-09-30 | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 22.8% | at 2025-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 22.9% | at 2025-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 24.1% | at 2024-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 34
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2025-09-30 | −¥282m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2025-09-30 | −¥282m |
| Application Servicereportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥4.9bn |
| Application Servicereportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥4.7bn |
| Application Servicereportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥155m |
| Application Servicereportable segment | segment profit | 2025-04-01 → 2025-09-30 | −¥54m |
| Information Infrastructurereportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥24.4bn |
| Information Infrastructurereportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥24.2bn |
| Information Infrastructurereportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥127m |
| Information Infrastructurereportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥2.9bn |
| Medical System Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥4.4bn |
| Medical System Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥4.4bn |
| Medical System Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥302m |
| —segment total | revenue | 2025-04-01 → 2025-09-30 | ¥33.7bn |
| —segment total | revenue external | 2025-04-01 → 2025-09-30 | ¥33.4bn |
| —segment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥282m |
| —segment total | segment profit | 2025-04-01 → 2025-09-30 | ¥3.2bn |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥241m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥241m |
| Application Servicereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥4.5bn |
| Application Servicereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥4.4bn |
| Application Servicereportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥139m |
| Application Servicereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥159m |
| Information Infrastructurereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥22.1bn |
| Information Infrastructurereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥22.0bn |
| Information Infrastructurereportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥102m |
| Information Infrastructurereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥2.6bn |
| Medical System Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥4.4bn |
| Medical System Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥4.4bn |
| Medical System Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥305m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥31.1bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥30.8bn |
| —segment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥241m |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥3.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 821
| Item | Context | Value | Unit |
|---|---|---|---|
| Effect of exchange rate changes on cash and cash equivalents IFRS | InterimDuration | 33512000 | JPY |
| Net increase decrease in cash and cash equivalents IFRS | Prior1InterimDuration | 257137000 | JPY |
| Net increase decrease in cash and cash equivalents IFRS | InterimDuration | 3715373000 | JPY |
| Cash and cash equivalents IFRS | Prior2YearInstant | 27265398000 | JPY |
| Cash and cash equivalents IFRS | Prior1YearInstant | 27325233000 | JPY |
| Cash and cash equivalents IFRS | Prior1InterimInstant | 27522536000 | JPY |
| Cash and cash equivalents IFRS | InterimInstant | 31040606000 | JPY |
| Revenue from external customers IFRS | Prior1InterimDuration_jpcrp040300-ssr_E05463-000InformationInfrastructureReportableSegmentMember | 22046904000 | JPY |
| Revenue from external customers IFRS | Prior1InterimDuration_jpcrp040300-ssr_E05463-000ApplicationServiceReportableSegmentMember | 4385841000 | JPY |
| Revenue from external customers IFRS | Prior1InterimDuration_jpcrp040300-ssr_E05463-000MedicalSystemBusinessReportableSegmentMember | 4409058000 | JPY |
| Revenue from external customers IFRS | Prior1InterimDuration_ReportableSegmentsMember | 30841805000 | JPY |
| Revenue from external customers IFRS | Prior1InterimDuration_ReconcilingItemsMember | － | JPY |
| Revenue from external customers IFRS | Prior1InterimDuration | 30841805000 | JPY |
| Intersegment revenue IFRS | Prior1InterimDuration_jpcrp040300-ssr_E05463-000InformationInfrastructureReportableSegmentMember | 101979000 | JPY |
| Intersegment revenue IFRS | Prior1InterimDuration_jpcrp040300-ssr_E05463-000ApplicationServiceReportableSegmentMember | 138595000 | JPY |
| Intersegment revenue IFRS | Prior1InterimDuration_jpcrp040300-ssr_E05463-000MedicalSystemBusinessReportableSegmentMember | － | JPY |
| Intersegment revenue IFRS | Prior1InterimDuration_ReportableSegmentsMember | 240575000 | JPY |
| Intersegment revenue IFRS | Prior1InterimDuration_ReconcilingItemsMember | -240575000 | JPY |
| Intersegment revenue IFRS | Prior1InterimDuration | － | JPY |
| Revenue IFRS | Prior1InterimDuration_jpcrp040300-ssr_E05463-000InformationInfrastructureReportableSegmentMember | 22148884000 | JPY |
| Revenue IFRS | Prior1InterimDuration_jpcrp040300-ssr_E05463-000ApplicationServiceReportableSegmentMember | 4524437000 | JPY |
| Revenue IFRS | Prior1InterimDuration_jpcrp040300-ssr_E05463-000MedicalSystemBusinessReportableSegmentMember | 4409058000 | JPY |
| Revenue IFRS | Prior1InterimDuration_ReportableSegmentsMember | 31082380000 | JPY |
| Revenue IFRS | Prior1InterimDuration_ReconcilingItemsMember | -240575000 | JPY |
| Revenue IFRS | Prior1InterimDuration | 30841805000 | JPY |
| Operating profit loss IFRS | Prior1InterimDuration_jpcrp040300-ssr_E05463-000InformationInfrastructureReportableSegmentMember | 2559356000 | JPY |
| Operating profit loss IFRS | Prior1InterimDuration_jpcrp040300-ssr_E05463-000ApplicationServiceReportableSegmentMember | 159337000 | JPY |
| Operating profit loss IFRS | Prior1InterimDuration_jpcrp040300-ssr_E05463-000MedicalSystemBusinessReportableSegmentMember | 304529000 | JPY |
| Operating profit loss IFRS | Prior1InterimDuration_ReportableSegmentsMember | 3023223000 | JPY |
| Operating profit loss IFRS | Prior1InterimDuration_ReconcilingItemsMember | － | JPY |
| Operating profit loss IFRS | Prior1InterimDuration | 3023223000 | JPY |
| Finance income IFRS | Prior1InterimDuration | 83086000 | JPY |
| Finance costs IFRS | Prior1InterimDuration | 35070000 | JPY |
| Share of profit loss of investments accounted for using equity method IFRS | Prior1InterimDuration | -302840000 | JPY |
| Profit loss before tax IFRS | Prior1InterimDuration | 2768399000 | JPY |
| Revenue from external customers IFRS | InterimDuration_jpcrp040300-ssr_E05463-000InformationInfrastructureReportableSegmentMember | 24229899000 | JPY |
| Revenue from external customers IFRS | InterimDuration_jpcrp040300-ssr_E05463-000ApplicationServiceReportableSegmentMember | 4716048000 | JPY |
| Revenue from external customers IFRS | InterimDuration_jpcrp040300-ssr_E05463-000MedicalSystemBusinessReportableSegmentMember | 4431873000 | JPY |
| Revenue from external customers IFRS | InterimDuration_ReportableSegmentsMember | 33377822000 | JPY |
| Revenue from external customers IFRS | InterimDuration_ReconcilingItemsMember | － | JPY |
| Revenue from external customers IFRS | InterimDuration | 33377822000 | JPY |
| Intersegment revenue IFRS | InterimDuration_jpcrp040300-ssr_E05463-000InformationInfrastructureReportableSegmentMember | 127441000 | JPY |
| Intersegment revenue IFRS | InterimDuration_jpcrp040300-ssr_E05463-000ApplicationServiceReportableSegmentMember | 154732000 | JPY |
| Intersegment revenue IFRS | InterimDuration_jpcrp040300-ssr_E05463-000MedicalSystemBusinessReportableSegmentMember | － | JPY |
| Intersegment revenue IFRS | InterimDuration_ReportableSegmentsMember | 282174000 | JPY |
| Intersegment revenue IFRS | InterimDuration_ReconcilingItemsMember | -282174000 | JPY |
| Intersegment revenue IFRS | InterimDuration | － | JPY |
| Revenue IFRS | InterimDuration_jpcrp040300-ssr_E05463-000InformationInfrastructureReportableSegmentMember | 24357341000 | JPY |
| Revenue IFRS | InterimDuration_jpcrp040300-ssr_E05463-000ApplicationServiceReportableSegmentMember | 4870781000 | JPY |
| Revenue IFRS | InterimDuration_jpcrp040300-ssr_E05463-000MedicalSystemBusinessReportableSegmentMember | 4431873000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |